Clinical trial
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
NCT05410509 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 3, 2024
- Completion date
- November 19, 2025
- Enrollment
- 25 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma (rcc)